Stockholders' Equity (Tables)
|
6 Months Ended |
May 31, 2024 |
Fair Value of Options Granted |
Variables used to determine the fair value of the options granted for the three and six months ended May 31, 2024 and 2023, respectively, are as follows:
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
Six months ended |
|
|
May 31, |
|
May 31, |
|
May 31, |
|
May 31, |
|
|
2024 |
|
2023 |
|
2024 |
|
2023 |
Weighted average values: |
|
|
|
|
|
|
|
|
Expected dividends |
|
0% |
|
0% |
|
0% |
|
0% |
Expected volatility |
|
— |
|
— |
|
60.52% |
|
55.00% |
Risk free interest rate |
|
— |
|
— |
|
3.87% |
|
3.87% |
Expected life |
|
— |
|
— |
|
5 years |
|
5 years |
|
Stock Option Activity |
Stock option activity for options with only service-based vesting conditions for the six months ended May 31, 2024, was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
Weighted Average Remaining |
|
|
|
|
|
|
|
|
|
Average |
|
|
Contractual |
|
|
Aggregate |
|
|
|
Options |
|
|
Exercise Price |
|
|
Term (Years) |
|
|
Intrinsic Value |
|
Outstanding at November 30, 2023 |
|
|
404,278 |
|
|
$ |
7.36 |
|
|
4.49 |
|
|
$ |
135,330 |
|
Granted |
|
|
103,000 |
|
|
|
6.31 |
|
|
|
|
|
|
196,770 |
|
Exercised |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
Expired/forfeited |
|
|
(1,500 |
) |
|
|
7.04 |
|
|
|
|
|
|
1,770 |
|
Outstanding at May 31, 2024 |
|
|
505,778 |
|
|
$ |
7.14 |
|
|
|
4.11 |
|
|
$ |
884,103 |
|
Exercisable at May 31, 2024 |
|
|
375,718 |
|
|
$ |
7.50 |
|
|
|
4.06 |
|
|
$ |
594,908 |
|
|
Significant Option Groups Exercisable Option and its Price and Contractual Life |
Significant option groups outstanding and exercisable at May 31, 2024 and related price and contractual life information are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding |
|
|
Exercisable |
|
|
|
|
|
|
Weighted Average |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Remaining |
|
|
Weighted |
|
|
|
|
|
Weighted |
|
Range of Exercise Prices |
|
Outstanding |
|
|
Contractual Life (Years) |
|
|
Average Exercise Price |
|
|
Outstanding |
|
|
Average Exercise Price |
|
$3.01 to $4.00 |
|
|
25,000 |
|
|
|
1.69 |
|
|
$ |
3.13 |
|
|
|
25,000 |
|
|
$ |
3.13 |
|
$4.01 to $5.00 |
|
|
123,600 |
|
|
|
4.09 |
|
|
$ |
4.70 |
|
|
|
78,665 |
|
|
$ |
4.68 |
|
$5.01 to $6.00 |
|
|
28,000 |
|
|
|
4.56 |
|
|
$ |
5.88 |
|
|
|
9,332 |
|
|
$ |
5.88 |
|
$6.01 to $7.00 |
|
|
89,433 |
|
|
|
4.91 |
|
|
$ |
6.48 |
|
|
|
39,430 |
|
|
$ |
6.48 |
|
$7.01 to $8.00 |
|
|
149,645 |
|
|
|
4.86 |
|
|
$ |
7.54 |
|
|
|
142,443 |
|
|
$ |
7.52 |
|
$9.01 to $10.00 |
|
|
29,000 |
|
|
|
3.76 |
|
|
$ |
9.37 |
|
|
|
21,583 |
|
|
$ |
9.37 |
|
$12.01 to $13.00 |
|
|
16,653 |
|
|
|
6.23 |
|
|
$ |
12.54 |
|
|
|
14,818 |
|
|
$ |
12.55 |
|
$13.01 to $14.00 |
|
|
44,447 |
|
|
|
0.56 |
|
|
$ |
13.50 |
|
|
|
44,447 |
|
|
$ |
13.50 |
|
|
|
|
505,778 |
|
|
|
4.11 |
|
|
$ |
7.14 |
|
|
|
375,718 |
|
|
$ |
7.50 |
|
|
Summary of Non-Vested Options |
A summary of the status of the Company’s non-vested options as of May 31, 2024, and changes during the six months ended May 31, 2024, is presented below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted Average |
|
|
|
|
|
|
Grant-Date |
|
|
|
Options |
|
|
Fair Value |
|
Non-vested at November 30, 2023 |
|
|
114,193 |
|
|
$ |
3.10 |
|
Granted |
|
|
103,000 |
|
|
|
3.13 |
|
Vested |
|
|
(87,133 |
) |
|
|
3.30 |
|
Forfeited |
|
|
— |
|
|
|
— |
|
Non-vested at May 31, 2024 |
|
|
130,060 |
|
|
$ |
2.99 |
|
|